Instalab

Minimum FFRCT - LAD Test

A noninvasive read on whether a blockage in your most important heart artery is actually starving the muscle.

Should you take a Minimum FFRCT - LAD test?

This test is most useful if any of these apply to you.

Told You Have Plaque on a Heart CT
If a coronary CT angiogram showed narrowing, this number tells you whether the blockage is limiting blood flow or just sitting there.
Family History of Early Heart Disease
If a parent or sibling had a heart attack young, this reads whether disease is already affecting flow in your most important artery.
Chest Pain That Comes and Goes
If you have stable angina or unexplained chest discomfort, this can identify whether a specific narrowing is the culprit, without a catheter.
Living With a Transplanted Heart
If you have had a heart transplant, tracking this number can catch the diffuse coronary disease that can develop without symptoms.

About Minimum FFRCT - LAD

The artery running down the front of your heart, called the left anterior descending or LAD, feeds the largest territory of heart muscle. When something goes wrong here, the consequences are bigger than anywhere else in the coronary tree. The question is rarely whether you have some plaque. The question is whether that plaque is actually choking off blood flow.

Minimum FFRCT in the LAD answers that question without a catheter. A standard heart CT shows the shape of the artery. This number, computed from that same scan, tells you whether the narrowing is severe enough to starve muscle of blood during peak demand. It is the difference between seeing a partially blocked pipe and knowing whether water is still flowing through it.

What This Number Actually Is

FFRCT (fractional flow reserve from computed tomography) is not a molecule, hormone, or blood test. It is a ratio: the pressure of blood downstream of a narrowing divided by the pressure upstream, simulated by a computer model using your CT images and assumptions about how blood flows under maximum demand. A perfect, unobstructed artery would score 1.0. Lower numbers mean more pressure is being lost as blood squeezes past a blockage.

The "minimum" in Minimum FFRCT - LAD refers to the lowest simulated pressure ratio found anywhere along the LAD. It captures the worst spot in the artery rather than averaging across the whole vessel. Because the LAD supplies more heart muscle than any other coronary artery, even modest pressure drops here can carry outsized consequences.

Why the LAD Deserves Its Own Number

The LAD typically shows lower FFR values than the right coronary or circumflex arteries for the same degree of visible narrowing. This is partly because it supplies a much larger area of muscle, so the downstream demand is greater and the pressure drop across any obstruction is amplified. A 60 percent narrowing in the LAD is not equivalent to a 60 percent narrowing elsewhere.

In one analysis comparing FFRCT to invasive measurements in stable coronary disease, accuracy was higher in the LAD than in non-LAD vessels. Vessel-specific interpretation matters, and the LAD is where this number tends to be most informative.

Heart Attack and Revascularization Risk

The standard cutoff is 0.80. Values at or below this threshold are considered hemodynamically significant, meaning the narrowing is severe enough to limit blood flow under stress. In a 1-year analysis of more than 5,000 patients in an international registry, those with FFRCT above 0.80 had significantly lower rates of cardiovascular death or heart attack compared with those who scored at or below the threshold.

In a separate cohort of 206 patients followed long-term, a value of 0.80 or less was a better predictor of future revascularization (bypass surgery or stenting) than the visible degree of narrowing on the CT scan alone. The number itself sits on a risk continuum: a score of 0.70 carries more concern than 0.85, even though both fall below the cutoff.

Recurrent Chest Pain in Stable Angina

For people already diagnosed with stable angina, this number predicts whether chest pain is likely to come back. In a study of 267 patients with new-onset stable angina, lower per-patient minimum FFRCT values tracked closely with recurrent chest pain over follow-up. The lower the number, the more likely symptoms returned.

After Heart Transplantation

Transplanted hearts develop a specific form of coronary disease called cardiac allograft vasculopathy, which is diffuse rather than focal. In 73 heart transplant recipients, 74 percent had distal LAD FFRCT below 0.90 and 18 percent had at least one vessel at or below 0.80, even without any visible focal narrowing. Over two years of follow-up in 106 transplant patients, median distal LAD FFRCT dropped slightly (from 0.85 to 0.84) as stenoses accumulated. Tracking this number over time is one of the few noninvasive ways to monitor the progression of this specific complication.

Reconciling a Counterintuitive Finding

Here is something that catches people off guard. A study of 98 asymptomatic marathon runners with completely normal-looking coronary arteries found that 32 percent had distal LAD FFRCT at or below 0.80, with mean distal LAD FFRCT of 0.81 compared with 0.93 in the middle segment and 0.98 proximally. These were healthy athletes with no visible disease.

This is not a contradiction. It reflects the geometry of how blood flow is modeled in narrowing vessels. The very distal LAD is a small-caliber segment, and pressure naturally drops as the artery tapers. A low number in the far distal vessel does not necessarily mean obstructive disease. This is why the location of the measurement matters as much as the value itself, and why interpretation has to integrate anatomy, symptoms, and clinical context.

Reference Ranges

These thresholds come from large registries and outcome studies, primarily in symptomatic patients with suspected coronary disease. The number is a continuous risk indicator, not a clean cutoff. Borderline values near 0.80 carry measurement uncertainty and should be read alongside symptoms and the anatomic findings on the CT scan.

RangeWhat It SuggestsTypical Implication
Above 0.90No flow limitationVery low rates of heart attack or cardiovascular death in stable disease
0.81 to 0.90Mild physiologic impactOften safe to defer invasive testing, monitor over time
At or below 0.80Hemodynamically significantHigher rates of revascularization and major cardiac events; usually warrants further evaluation

Sources: ADVANCE Registry (Patel et al., 2020), Ihdayhid et al. 2019, Madsen et al. 2021. These ranges apply to symptomatic adults with suspected or known coronary disease. The same thresholds may produce false positives in asymptomatic, low-risk individuals, particularly in the very distal LAD.

Tracking the Trend Over Time

A single FFRCT value tells you what your physiology looked like on the day of the scan. It does not tell you which direction you are heading. The transplant data illustrate why serial measurements matter: over two years, distal LAD FFRCT declined as new stenoses developed, often before symptoms emerged.

If your initial scan shows a value above 0.80 and you have intermediate-grade narrowing on the CT, repeating the scan in 2 to 3 years (or sooner if symptoms change) gives you a trajectory. If your value is at or below 0.80, the trend matters even more. A stable number on optimal therapy is reassuring. A declining number signals progression and changes the calculus around invasive evaluation.

What to Do With an Abnormal Result

A value at or below 0.80 in the LAD is not a diagnosis on its own. It is a signal that the narrowing seen on the CT is likely doing real physiologic damage. The next steps depend on the specifics. A value between 0.75 and 0.80 in a stable, asymptomatic person may warrant medical optimization and repeat imaging. A value below 0.75, especially with symptoms, typically prompts referral to a cardiologist for consideration of invasive angiography and possible revascularization.

Companion information that strengthens or weakens the case for intervention includes the visible degree of narrowing on the CT, the location along the LAD (proximal disease carries more weight than distal), the presence of high-risk plaque features, the calcium score, and your symptom pattern. A lipidologist or preventive cardiologist can help build the medical therapy plan; an interventional cardiologist makes the call on procedures.

When Results Can Be Misleading

Several factors can produce a value that does not reflect true obstructive disease:

  • Measurement location: in a study of 930 patients, 61 percent of distal positive FFRCT results became negative when measured just 10.5 mm distal to the stenosis rather than at the far distal vessel. Where the value is read along the artery changes the answer.
  • Heavy coronary calcification: extensive calcium can distort the CT images and lead to underestimation of true vessel dimensions, particularly in the proximal LAD.
  • Coronary spasm: transient artery spasm can lower FFRCT even when fixed plaque is not the dominant issue. The number should be interpreted alongside symptom history.
  • Very distal small-caliber segments: low values in the far distal LAD can occur without any visible stenosis, particularly in lean, athletic individuals. These results should not drive invasive procedures in isolation.

How This Test Fits the Bigger Picture

A standard cholesterol panel tells you about risk factors. A coronary calcium score tells you whether disease has started. A coronary CT angiogram shows you the anatomy of any plaque present. Minimum FFRCT - LAD adds the missing piece: whether that plaque is actually limiting flow right now. It is the bridge between knowing you have disease and knowing whether that disease is doing functional damage.

What Moves This Biomarker

Evidence-backed interventions that affect your Minimum FFRCT - LAD level

↑ Increase
PCSK9 inhibitor (alirocumab or evolocumab) added to high-intensity statin therapy
PCSK9 inhibitors drive aggressive LDL lowering and produce measurable coronary plaque regression on intravascular imaging. In the PACMAN-AMI trial of 300 patients with acute myocardial infarction, alirocumab added to high-intensity statin therapy significantly improved plaque regression in non-infarct-related arteries over 52 weeks. Less plaque means less pressure drop along the LAD, which raises this number.
MedicationStrong Evidence
↑ Increase
Intensive lifestyle change combining a low-fat plant-based diet, regular exercise, stress management, and smoking cessation
Sustained lifestyle change can shift the underlying biology this number tracks. In a randomized trial of 48 patients with coronary disease followed for 5 years, intensive lifestyle intervention produced regression of coronary atherosclerosis and fewer cardiac events compared with usual care. Less plaque burden means less pressure drop across the artery, which is what this number captures.
LifestyleModerate Evidence
↑ Increase
Combined low-fat diet plus structured aerobic exercise
In a randomized trial of 113 men with stable angina, the diet plus exercise group showed slower progression and more regression of coronary stenosis on angiography compared with controls over 1 year. Less anatomic disease means a higher (better) downstream pressure ratio, the quantity this test measures.
LifestyleModerate Evidence
↑ Increase
Mediterranean diet rich in extra-virgin olive oil
In a randomized trial of 1,002 patients with established coronary heart disease, a Mediterranean diet rich in extra-virgin olive oil was associated with decreased progression of atherosclerosis compared with a low-fat diet. Slower anatomic progression preserves the downstream pressure that this number reflects.
DietModerate Evidence
↑ Increase
Ezetimibe added to a statin
In the PRECISE-IVUS trial of 202 patients undergoing percutaneous coronary intervention, ezetimibe plus atorvastatin produced greater coronary plaque regression than atorvastatin alone. Smaller plaque burden translates to less flow limitation, which is what this number captures.
MedicationModerate Evidence
↑ Increase
High-dose omega-3 fatty acids added to statin therapy
In an observational study of 210 patients with acute coronary syndrome on statins, adding high-dose omega-3 fatty acids was associated with a lower rate of plaque progression on serial CT angiography. Slower plaque progression preserves the downstream pressure ratio.
SupplementModest Evidence

Frequently Asked Questions

References

19 studies
  1. Cami E, Tagami T, Raff G, Fonte TA, Renard BM, Gallagher MJ, Chinnaiyan K, Bilolikar a, Fan a, Hafeez a, Safian RJournal of Cardiovascular Computed Tomography2018
  2. Gassenmaier S, Tsiflikas I, Greulich S, Kuebler J, Hagen F, Nikolaou K, Niess a, Burgstahler C, Krumm PEuropean Radiology2021
  3. Budde R, Nous F, Roest S, Constantinescu a, Nieman K, Brugts J, Koweek L, Hirsch a, Leipsic J, Manintveld OEuropean Radiology2021
  4. Sharma SP, Sanz J, Hirsch a, Patel R, Constantinescu a, Barghash M, Mancini DM, Brugts J, Caliskan KC, Taverne Y, Manintveld O, Budde RPJEuropean Radiology2024
  5. Seo C, Kim H, Koh JJournal of Clinical Medicine2025